Moderna said the Food and Drug Administration has agreed to review its experimental mRNA flu shot, reversing an earlier decision to refuse to accept the application.

The US drug regulator has allowed a key Moderna flu vaccine trial to proceed, reversing an earlier decision to halt the study that triggered a backlash from the company and wider biotech industry.